Drug Database
Back to search

France· FR:63977461

POLYSTYRENE SULFONATE DE SODIUM SUBSTIPHARM 454 g, poudre pour suspension orale et rectale

A medicinal product containing polystyrène sulfonate de sodium, registered in France by SUBSTIPHARM, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPOLYSTYRENE SULFONATE DE SODIUM SUBST…ATC—REGISTER NO.FR:63977461PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about polystyrène sulfonate de sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
POLYSTYRÈNE SULFONATE DE SODIUM
Manufacturer
SUBSTIPHARM
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930272312
    1 flacon(s) polyéthylène haute densité (PEHD) de 454 g avec cuillère-mesure polypropylène
    EUR 18.79

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Polystyrène sulfonate de sodium in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All polystyrène sulfonate de sodium products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Resonium A
  • Belgium · Kayexalate Sodium
  • Cyprus · Resinsodio
  • Germany · Anti-Kalium Na, Elutit®-Natrium-As
  • Spain · Resinsodio
  • Finland · Resonium
  • United Kingdom (Northern Ireland) · Resonium A
  • Hungary · Resonium
  • Italy · Kayexalate
  • Luxembourg · Kayexalate Sodium
  • Netherlands · Natriumpolystyreensulfonaat Focus, Resonium A
  • Poland · Resonium A
  • Portugal · Resonium
  • Sweden · Resonium

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/91f21a81-2ff4-4ccf-aa96-51ad8f2e16ee
GET /v1/drugs/91f21a81-2ff4-4ccf-aa96-51ad8f2e16ee?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63977461",
  "date_amm": "2023-04-18",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "POLYSTYRÈNE SULFONATE DE SODIUM",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour suspension et",
  "voies_administration": "orale;rectale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about polystyrène sulfonate de sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console